Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target

Go back to Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
US BioTec Inc New Common Shares (NASDAQ: SBC) Delayed: 3.07 +0.12 (4.07%)
Previous Close $2.95    52 Week High $0.40 
Open $2.91    52 Week Low $0.40 
Day High $3.13    P/E N/A 
Day Low $2.91    EPS $0.00 
Volume 82,667